Genistein is an isoflavenoid that is abundant in soy beans. Genistein has b
een reported to have a wide range of biological activities and to play a ro
le in the diminished incidence of breast cancer in populations that consume
a soy-rich diet. Genistein was originally identified as an inhibitor of ty
rosine kinases; however, it also inhibits topoisomerase II by stabilizing t
he covalent DNA cleavage complex, an event predicted to cause DNA damage. T
he topoisomerase II inhibitor etoposide acts in a similar manner. Here we s
how that genistein induces the up-regulation of p53 protein, phosphorylatio
n of p53 at serine 15, activation of the sequence-specific DNA binding prop
erties of p53, and phosphorylation of the hCds1/Chk2 protein kinase at thre
onine 68. Phosphorylation and activation of p53 and phosphorylation of Chk2
were not observed in ATM-deficient cells. In contrast, the topoisomerase I
I inhibitor etoposide induced phosphorylation of p53 and Chk2 in ATM-positi
ve and ATM-deficient cells. In addition, genistein-treated ATM-deficient ce
lls were significantly more susceptible to genistein-induced killing than w
ere ATM-positive cells. Together our data suggest that ATM is required for
activation of a DNA damage-induced pathway that activates p53 and Chk2 in r
esponse to genistein.